PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNotices
BuyersSuppliersNotices
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Kent Pharma Ltd
KP

Kent Pharma Ltd

Ashford
Large

Kent Pharma (part of the Kent-Athlone group) is a UK pharmaceutical company specialising in the licensing, development, and distribution of branded and generic medicines for the UK and Irish markets. The company has a strong portfolio of hospital and community medicines supplied to the NHS. Kent Pharma is known for its specialist hospital products and niche therapeutic areas.

kent-athlone.com ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£842.3m
Live
57
Buyers
12
12m
£752.5m
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities4
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts57 / 86
  • Top buyers12
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — Kent Pharma LtdUpdated 06 Jul 2026

At a glance · for buyers and watchdogs

Kent Pharma Ltd has won £842.3m across 12 public-sector buyers, with 57 live contracts. No active Companies House risk flags.

Why: top buyer NHS England at 98% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
ActiveCompany status
57 of 86Live contracts
98%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value · 1/5

Commitments mapped to the Government Social Value Model themes. Each is tagged self-reported or from the website.

◐ From supplier website
JobsNo commitment stated✓
SkillsNo commitment stated✓
Environment1 commitment✓
Tackling inequalityNo commitment stated✓
CommunityNo commitment stated✓
Environment · 1
  • WebsiteSustainabilityCommitted to responsible pharmaceutical supply and regulatory compliance to ensure safe medicines reach patients.

Extracted automatically from kent-athlone.com on Jun 2026. Not independently verified — treat as the supplier’s own marketing claims.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

◐ From website & notices
Sectors served · 1/8
Central government✓
Local government✓
NHS & health✓
Housing✓
Utilities & energy✓
Financial services✓
Education✓
Defence✓
Services · 5
Branded pharmaceutical products
Generic medicines
Hospital medicines supply
NHS medicines distribution
Pharmaceutical licensing
Frameworks & DPS · 4 from notices
  • NHS Framework Agreement for Branded medicines - NationalNHS England · £6.1m
  • Supportive Medicines including ITU, EOL & AntibioticsDepartment of Health and Social Care (T&T) · £1.7m
  • NHS National Pharmaceuticals Transition 2022_1NHS England and NHS Improvement · £944k
  • Contract for the supply of strategic stockpile of medicines 2021Department of Health and Social Care (T&T) · £329k

Extracted automatically from kent-athlone.com on Jun 2026. Not independently verified — treat as the supplier’s own marketing claims.

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships · 3

Credentials listed on the supplier’s website. Not yet checked against issuer registers.

◐ From supplier website
Core credentials · 0/6
Cyber EssentialsNot evidenced✓
Cyber Essentials PlusNot evidenced✓
ISO 27001 — Information securityNot evidenced✓
ISO 9001 — QualityNot evidenced✓
ISO 14001 — EnvironmentalNot evidenced✓
ISO 45001 — Health & safetyNot evidenced✓
Other credentials & memberships · 3
MHRA licensed
GDP compliant
GMP compliant

Extracted automatically from kent-athlone.com on Jun 2026. Not independently verified — treat as the supplier’s own marketing claims.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 57 live · 29 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
Generic Drugs – Injections/Infusions 2
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)—01 Jul 2026£5.9m12 mopending
NHS National Generic Pharmaceuticals - Wave 15c
NHS England—01 Jun 2026£403.7m2 yrspending
NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products
NHS England—01 Mar 2026£321.3m2 yrspending
NHS National Framework for Generics Housekeeping
NHS England—01 Feb 2026£21.6m1.7 yrspending
NHS National Framework - Generics Housekeeping/Supply Chain Resilience Products
NHS England3360000001 Jun 2025£376k2 yrsLive
NHS National Framework for Transition products commencing 1 May 2024
NHS England3360000001 May 2024£630k17 moClosed
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)
NHS England3360000001 Jun 2024£0.023 yrsLive
NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024
NHS England3360000001 Mar 2024£17.6m2.5 yrsLive
NHS London Branded Medicines - Tranche B - September 2023
NHS England3360000001 Sept 2023£6.4m2 yrsClosed
NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals
NHS England3360000001 May 2023£6.1m2 yrsClosed
Total live value £18.0m · mean award £9.8m1–10 of 86

Top buyers · 12 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS England
28 contracts
98%
since 2019
2
Department of Health and Social Care (T&T)
14 contracts
1%
since 2020
3
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
1 contract
1%
since 2026
4
Department of Health & Social Care
1 contract
0%
since 2019
5
NHS England and NHS Improvement
1 contract
0%
since 2022
6
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
1 contract
0%
since 2022
7
COMMERCIAL MEDICINES UNIT
2 contracts
0%
since 2017
8
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
19 contracts
0%
9
Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)
12 contracts
0%
10
The NHS Commissioning Board (operating under the name of NHS England)
4 contracts
0%

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
Yorkshire29 contracts
99%
Wales14 contracts
1%
London2 contracts
0%
Scotland19 contracts
0%
North West4 contracts
0%
Northern Ireland2 contracts
0%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Kent Pharma Ltd highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
KP
Kent Pharma Ltd
No£752.5m—
DR
Dr Reddy's Laboratories (UK) Ltd
Yes£121.0m22
JA
Janssen-Cilag Ltd
Yes£117.6m18
AB
AbbVie Ltd
Yes£95.2m12
TA
Thornton and Ross Ltd
Yes£72.5m12
AC
ACCORD-UK LTD
Yes£71.2m21
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
✓ Clean. No active risk signals from Companies House status, charges or insolvency records.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
Trading status
Active
Live at Companies House
Annual accounts
Up to date
Last made up to 31 Mar 2025
Confirmation statement
Due in -44d
Next due 29 May 2026
Outstanding charges
0
No charges registered
Insolvency history
None
No insolvency cases registered
Certifications (ISO, Cyber Essentials, Living Wage, B-Corp, modern-slavery) are supplier self-reported and appear once a claimed profile adds them.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Live sync — registered details, directors, PSC and SIC codes.

✓ Live sync

Registered details

Company no.
03371228
Status
Active
Type
Private limited
Incorporated
15 May 1997
Reg. office
2nd Floor, Connect 38 1 Dover Place, Ashford, Kent, TN23 1FB
SIC codes
21100
Last accounts
31 Mar 2025
Next accounts due
31 Dec 2026

Directors & PSC

  • JAMES, Kevin — director
    Appointed 23 Mar 2022
  • WRIGHT, David — director
    Appointed 16 Sept 2019
  • Kent Pharma Holdings Limited — person with significant control
    ownership of shares 75 to 100 percent · voting rights 75 to 100 percent · right to appoint and remove directors · significant influence or control as firm

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
KENT PHARMACEUTICALS LIMITED
03371228 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.